Filtered By:
Condition: Atrial Fibrillation
Procedure: Heart Valve Surgery

This page shows you your search results in order of relevance. This is page number 20.

Order by Relevance | Date

Total 444 results found since Jan 2013.

Aortic Valve Predilatation with a Small Balloon, without Rapid Pacing, prior to Transfemoral Transcatheter Aortic Valve Replacement.
Conclusion: In TAVR, AVPD with a small, nonocclusive balloon can be safely performed. By avoiding rapid pacing, this technique may be a valid alternative to traditional BAV. Whether or not the use of APVD without rapid pacing translates into less periprocedural complications needs to be assessed in future studies. PMID: 29854723 [PubMed - in process]
Source: Biomed Res - June 3, 2018 Category: Research Authors: Shivaraju A, Thilo C, Sawlani N, Ott I, Schunkert H, von Scheidt W, Kastrati A, Kasel AM Tags: Biomed Res Int Source Type: research

Long-standing persistent effects of atrial volume reduction combined with pulmonary vein isolation
Publication date: Available online 18 June 2018 Source:Journal of Cardiology Cases Author(s): Masami Takagaki, Naoko Ikeda, Hiroki Yamaguchi, Shinichi Mitsuyama, Tasuku Kadowaki, Tatsuya Nakao Although surgical left atrial (LA) volume reduction combined with mitral valve surgery and/or surgical ablation for atrial fibrillation has been reported to be effective, its long-term outcomes in the absence of mitral procedure are not well established. A 74-year-old man with two previous sternotomies—the first for pericardiectomy due to constrictive pericarditis and the second for mitral valve replacement with mechanical valve a...
Source: Journal of Cardiology Cases - June 20, 2018 Category: Cardiology Source Type: research

Use of an Automated Suture Fastening Device in Minimally Invasive Aortic Valve Replacement
Conclusions In mAVR, the CK device was associated with reduced aortic cross-clamp time while providing equivalent clinical outcomes. Larger studies are needed to confirm the efficacy, safety, and cost-effectiveness of the CK device in minimally invasive aortic valve surgery.
Source: The Annals of Thoracic Surgery - June 22, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Three-Year Survival Comparison Between Transcatheter and Surgical Aortic Valve Replacement for Intermediate- and Low-Risk Patients
Transcatheter aortic valve implantation is a suitable therapeutic intervention for patients deemed inoperable or high risk for surgical aortic valve replacement. Current investigations question whether it is a suitable alternative to surgery for intermediate- and low-risk patients. The following meta-analysis presents a comparison between transcatheter versus surgical aortic valve replacement in patients that are intermediate and low risk for surgery. Articles were collected via an electronic search using Google Scholar and PubMed. Articles of interest included studies comparing the survival of intermediate- and low-risk p...
Source: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery - May 1, 2018 Category: Cardiovascular & Thoracic Surgery Tags: Review Article Source Type: research

Use of an Automated Suture Fastening Device in Minimally Invasive Aortic Valve Replacement
ConclusionsIn mAVR, the CK device was associated with reduced aortic cross-clamp time while providing equivalent clinical outcomes. Larger studies are needed to confirm the efficacy, safety, and cost-effectiveness of the CK device in minimally invasive aortic valve surgery.
Source: The Annals of Thoracic Surgery - July 5, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Long-standing persistent effects of atrial volume reduction combined with pulmonary vein isolation
Publication date: Available online 18 June 2018Source: Journal of Cardiology CasesAuthor(s): Masami Takagaki, Naoko Ikeda, Hiroki Yamaguchi, Shinichi Mitsuyama, Tasuku Kadowaki, Tatsuya NakaoAbstractAlthough surgical left atrial (LA) volume reduction combined with mitral valve surgery and/or surgical ablation for atrial fibrillation has been reported to be effective, its long-term outcomes in the absence of mitral procedure are not well established. A 74-year-old man with two previous sternotomies—the first for pericardiectomy due to constrictive pericarditis and the second for mitral valve replacement with mechanical va...
Source: Journal of Cardiology Cases - July 5, 2018 Category: Cardiology Source Type: research

Use of an Automated Suture Fastening Device in Minimally Invasive Aortic Valve Replacement
ConclusionsIn mAVR, the CK device was associated with reduced aortic cross-clamp time while providing equivalent clinical outcomes. Larger studies are needed to confirm the efficacy, safety, and cost-effectiveness of the CK device in minimally invasive aortic valve surgery.
Source: The Annals of Thoracic Surgery - July 10, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Long-standing persistent effects of atrial volume reduction combined with pulmonary vein isolation
Publication date: Available online 18 June 2018Source: Journal of Cardiology CasesAuthor(s): Masami Takagaki, Naoko Ikeda, Hiroki Yamaguchi, Shinichi Mitsuyama, Tasuku Kadowaki, Tatsuya NakaoAbstractAlthough surgical left atrial (LA) volume reduction combined with mitral valve surgery and/or surgical ablation for atrial fibrillation has been reported to be effective, its long-term outcomes in the absence of mitral procedure are not well established. A 74-year-old man with two previous sternotomies—the first for pericardiectomy due to constrictive pericarditis and the second for mitral valve replacement with mechanical va...
Source: Journal of Cardiology Cases - July 10, 2018 Category: Cardiology Source Type: research

Boston Scientific puts $270m on the table for Claret Medical
Boston Scientific (NYSE:BSX) said today that it agreed to pay as much as $270 million to acquire Claret and its Sentinel device. Marlborough, Mass.-based Boston Scientific said the deal involves an ip-front cash payment of $220 million and another $50 million pegged to a reimbursement milestone. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage. After landing CE Mark approval in the European Union in 2014, Santa Rosa, Calif.-based Claret won de novo clearance from the FDA last year for the Sentinel d...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Replacement Heart Valves Wall Street Beat Boston Scientific Claret Medical Inc. Source Type: news

Reinventing the atrial fibrillation wheel
In this issue of the Journal, Mehta and colleagues1 report their 10-year experience with “De Novo Atrial Fibrillation After Mitral Valve Surgery,” defined as new-onset atrial fibrillation (AF) occurring more than 90 days after discharge. The cause was heterogeneous, with half of the patients having degenerative pathology. The incidence of de novo AF was 14% and 23% at 5 and 10 yea rs, respectively. Multivariable risk factors were tricuspid valve surgery, aortic valve surgery, and older age. Obviously, significantly more patients with AF were anticoagulated, with a strong but not significant trend toward an increased risk of stroke.
Source: The Journal of Thoracic and Cardiovascular Surgery - July 15, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Isidore Dinga Madou, Tsuyoshi Kaneko, Sary F. Aranki Tags: Editorial Commentary Source Type: research

Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined with Mitral Valve Surgery
ConclusionsSurgical AF ablation using robotic-assistance in the setting of mitral valve surgery showed excellent safety and favorable long-term clinical outcomes.
Source: The Annals of Thoracic Surgery - October 12, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined with Mitral Valve Surgery.
CONCLUSIONS: Surgical AF ablation using robotic-assistance in the setting of mitral valve surgery showed excellent safety and favorable long-term clinical outcomes. PMID: 30316854 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - October 11, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Ju MH, Huh JH, Lee CH, Kim HJ, Je HG, Kim JB, Jung SH, Lee JW Tags: Ann Thorac Surg Source Type: research

Early Hemodynamic Performance of the Crown PRT Aortic Prosthesis: A Prospective Study.
CONCLUSIONS: The Crown PRT is an effective bioprosthesis, with a low incidence of valve-related complications comparable to those of other current bioprostheses. The bioprosthesis demonstrated satisfactory results in terms of hemodynamics and freedom from reoperation. PMID: 30560604 [PubMed - in process]
Source: Journal of Heart Valve Disease - December 19, 2018 Category: Cardiology Tags: J Heart Valve Dis Source Type: research

Thromboembolic and bleeding risk stratification according to the EHRA valvular heart disease classification in patients with atrial fibrillation
ConclusionThis systematic analysis in real life conditions shows that distinguishing AF patients according to the new EHRA valve classification could be relevant for creating more homogenous groups of patients in terms of TE and bleeding risk. This clearer classification than the previous one should be useful as in clinical research for harmonization of studies, as well as in clinical practice for targeted choices of OAC therapy.
Source: Archives of Cardiovascular Diseases Supplements - December 25, 2018 Category: Cardiology Source Type: research

Oral Anticoagulation.
CONCLUSION: The evidence base for anticoagulation over a time frame of several years is inadequate at present, and direct comparative data for the different types of NOAC are not yet available. PMID: 30602410 [PubMed - in process]
Source: Deutsches Arzteblatt International - January 5, 2019 Category: General Medicine Tags: Dtsch Arztebl Int Source Type: research